Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001352413-18-000004

President & C.E.O. sold 80,000 shares at $41.00 ($3,280,000)

  • President & C.E.O. acquired 80,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Capone Mark Christopher · President & C.E.O.

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-07-11 Exercise or conversion : show line 1 in the form +77,654 $30.12 $2,338,938 409,829 D
2018-07-11 Sale : show line 2 in the form −77,654 $41.00 $3,183,814 332,175 D
2018-07-11 Exercise or conversion : show line 3 in the form +2,346 $30.12 $70,662 334,521 D
2018-07-11 Sale : show line 4 in the form −2,346 $41.00 $96,186 332,175 D
Open-market sales · 80,000 sh · avg $41.00 · $3,280,000

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-07-11 Exercise or conversion : show line 5 in the form Incentive Stock Option (right to buy) −2,346 $30.12 2019-02-18 2,346 0 D
2018-07-11 Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) −77,654 $30.12 2019-02-18 77,654 0 D
Loading xslF345X03/edgardoc.xml…